Zhejiang Wecome Pharmaceutical Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top 17 shareholders own 76.32% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
69%	Zhongliang Liu	98,032,430	CN¥1.4b	0%	no data
4.17%	Lishui Shunze Investment Management Partnership Enterprise (Limited Partnership)	5,923,215	CN¥83.8m	0%	no data
0.63%	Xiaoxia Kong	888,484	CN¥12.6m	0%	no data
0.59%	Golden Trust SinoPac Fund Management Co., Ltd.	835,048	CN¥11.8m	-3.74%	0.07%
0.29%	Weifang Lu	409,220	CN¥5.8m	0%	no data
0.28%	CITIC Securities Company Limited, Asset Management Arm	400,596	CN¥5.7m	0%	0.01%
0.27%	Shanghai Guotai Junan Securities Asset Management Co., Ltd.	378,825	CN¥5.4m	31.2%	0.02%
0.25%	Dexiong Dai	348,181	CN¥4.9m	0%	no data
0.24%	Barclays PLC Private Banking & Investment Banking Investment	347,075	CN¥4.9m	0%	no data
0.2%	UBS Asset Management AG	290,352	CN¥4.1m	-11.8%	no data
0.19%	Morgan Stanley, Investment Banking and Brokerage Investments	270,311	CN¥3.8m	0%	no data
0.16%	Goldman Sachs Group, Investment Banking and Securities Investments	224,732	CN¥3.2m	0%	no data
0.015%	China Southern Asset Management Co., Ltd.	21,100	CN¥298.5k	0%	no data
0.014%	Wanjia Asset Management Co., Ltd.	19,500	CN¥276.0k	0%	no data
0.0097%	Huatai-PineBridge Fund Management Co., Ltd.	13,740	CN¥194.4k	0%	no data
0.0031%	ICBC Credit Suisse Asset Management Co., Ltd.	4,400	CN¥62.3k	0%	no data
0.0008%	Lion Fund Management Co. Ltd.	1,134	CN¥16.1k	0%	no data